๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hemostatic molecular markers in nephrotic syndrome

โœ Scribed by Tsai-Yun Chen; Chieng-Chung Huang; Chao-Jung Tsao


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
294 KB
Volume
44
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Hemostatic molecular markers before the
โœ Wada, Hideo; Sakuragawa, Nobuo; Mori, Yositaka; Takagi, Mikio; Nakasaki, Takahir ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

We retrospectively measured various hemostatic markers in 240 patients with disseminated intravascular coagulation (DIC) before the onset of DIC and in 110 non-DIC patients, and examined their usefulness for the diagnosis of pre-DIC. Changes in prothrombin time ratio and fibrinogen levels were not s

Coagulopathy in a patient with nephrotic
โœ Shari Ghanny; Catherine Ross; Anthony K.C. Chan; Howard H.W. Chan ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 2 views
Remission of myasthenia gravis caused by
โœ Malaz Almsaddi; Tulio E. Bertorini; William Bastnagel ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 30 KB ๐Ÿ‘ 1 views

Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production. We report a 43-year-old myasthenic female who was symptomatic until she developed proteinuria from nephrotic syndrome, which caused a marked drop in acetylc

Molecular markers in male breast carcino
โœ Daniel Rayson; Charles Erlichman; Vera J. Suman; Patrick C. Roche; Lester E. Wol ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 116 KB ๐Ÿ‘ 2 views

## BACKGROUND. In contrast to female breast carcinoma, information regarding the prevalence and prognostic information of new molecular markers is limited in male breast carcinoma. The objective of this study was to assess the degree of expression and prognostic value of estrogen receptors (ER), pr